Loading...
Back to narrative

AnalystConsensusTarget updated the narrative for AVA

Update shared on 02 Nov 2025

Fair value Decreased 0.98%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
8.9%
7D
0.7%

Avista's analyst fair value price target has been modestly reduced from $41.00 to $40.60 as analysts recalibrate their expectations in light of updated revenue growth and profitability forecasts.

What's in the News

  • Avista Corporation confirmed consolidated earnings guidance for the year ending December 31, 2025, with an expected earnings range of $2.52 to $2.72 per diluted share (Key Developments).
  • The company projects long-term earnings growth in the 4% to 6% range, using the 2025 forecast as the base year (Key Developments).

Valuation Changes

  • Consensus Analyst Price Target has been modestly reduced from $41.00 to $40.60.
  • Discount Rate remains unchanged at 6.78%.
  • Revenue Growth projection has increased slightly, from 3.12% to 3.21%.
  • Net Profit Margin has edged down marginally, from 11.44% to 11.42%.
  • Future P/E ratio has decreased from 17.71x to 17.52x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.